Commission Implementing Decision (EU) 2018/134

of 24 January 2018

amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products

(notified under document C(2018) 218)

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use1, and in particular Article 16f thereof,

Having regard to the opinion of the European Medicines Agency, formulated on 2 February 2016 by the Committee for Herbal Medicinal Products

Whereas:

(1)

Sideritis scardica Griseb., herba can be considered as a herbal substance, a herbal preparation or a combination thereof within the meaning of Directive 2001/83/EC and it complies with the requirements set out in that Directive.

(2)
It is therefore appropriate to include Sideritis scardica Griseb., herba in the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products established by Commission Decision 2008/911/EC2.
(3)

Decision 2008/911/EC should therefore be amended accordingly.

(4)

The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Medicinal Products for Human Use,

HAS ADOPTED THIS DECISION:

Article 1

Annexes I and II to Decision 2008/911/EC are amended in accordance with the Annex to this Decision.

Article 2

This Decision is addressed to the Member States.

Done at Brussels, 24 January 2018.

For the Commission

Vytenis Andriukaitis

Member of the Commission

ANNEX

Decision 2008/911/EC is amended as follows:

  1. (1)

    In Annex I, the following substance is inserted after Pimpinella anisum L:

    ‘Sideritis scardica Griseb., herba.’;

  2. (2)

    In Annex II, the following is inserted after the COMMUNITY LIST ENTRY on Pimpinella anisum L:

    ‘UNION LIST ENTRY ON SIDERITIS SCARDIA GRISEB., HERBA

    Scientific name of the plant

    Sideritis scardica Griseb.

    Botanical family

    Lamiaceae (Labiatae)

    Herbal substance

    Ironwort (Sideritis herba)

    Common name in all EU official languages of herbal preparation

    BG (bălgarski): Мурсалски чай, стрък

    CS (čeština): nať hojníku

    DA (dansk): Kortkroneurt

    DE (Deutsch): Balkan-Gliedkraut

    EL (elliniká): Πόα σιδηρίτου

    EN (English): Ironwort

    ES (español): Siderita, partes aéreas de

    ET (eesti keel): haavarohuürt

    FI (suomi): raudakki, verso

    FR (français): Crapaudine (parties aériennes de)

    HR (hrvatska): očistova zelen

    HU (magyar): sármányvirág virágos hajtása

    IT (italiano): Stregonia parti aeree fiorite

    LT (lietuvių kalba): Timsrų žolė

    LV (latviešu valoda): Siderītu laksts

    MT (Malti): ħaxixa tas-Sideritis

    NL (Nederlands): (Griekse) bergthee, kruid

    PL (polski): Ziele gojnika

    PT (português): Siderite, partes aéreas

    RO (română): iarba de ceaiul muntelui cretan

    SK (slovenčina): Vňať ránhoja

    SL (slovenščina): zel sklepnjaka

    SV (svenska): Sårmynta, ört

    IS (íslenska):

    NO (norsk): Gresk fjellte

    Herbal preparations

    Comminuted herbal substance

    European Pharmacopoeia monograph reference

    Not applicable

    Indications

    Indication (1)

    Traditional herbal medicinal product used for the relief of cough associated with cold.

    Indication (2)

    Traditional herbal medicinal product used for the relief of mild gastrointestinal discomfort.

    The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.

    Type of tradition

    European

    Specified strength

    Please see “Specified posology”.

    Specified posology

    Adults and elderly

    Indication (1) and (2)

    Single dose: Herbal tea: 2-4 g of the comminuted herbal substance in 150-200 ml of water as a herbal infusion 2-3 times daily

    Daily dose: up to 12 g

    The use in children and adolescents under 18 years of age is not recommended (see section “Special warnings and precautions for use”)

    Route of administration

    Oral use

    Duration of use or any restrictions on the duration of use

    Indication (1)

    If symptoms persist longer than 1 week during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.

    Indication (2)

    If symptoms persist longer than 2 weeks during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.

    Any other information necessary for the safe use

    Contraindications

    Hypersensitivity to the active substance and to other plants of the Lamiaceae (Labiatae) family.

    Special warnings and precautions for use

    The use in children and adolescents under 18 years of age has not been established due to lack of adequate data.

    If the symptoms worsen during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.

    Interactions with other medicinal products and other forms of interaction

    None reported

    Fertility, pregnancy and lactation

    Safety during pregnancy and lactation has not been established. In the absence of sufficient data, use during pregnancy and lactation is not recommended.

    No fertility data available.

    Effects on ability to drive and use machines

    No studies on the effect on the ability to drive and use machines have been performed.

    Undesirable effects

    None known

    If adverse reactions occur, a doctor or qualified health care practitioner should be consulted.

    Overdose

    No case of overdose has been reported.

    Pharmaceutical particulars (if necessary)

    Not applicable

    Pharmacological effects or efficacy plausible on the basis of long-standing use and experience (if necessary for the safe use of the product)

    Not applicable.’